INT124953

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.42
First Reported 2005
Last Reported 2008
Negated 1
Speculated 2
Reported most in Body
Documents 6
Total Number 8
Disease Relevance 1.97
Pain Relevance 1.75

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

endosome (Egfr) cell morphogenesis (Egfr) intracellular (Egfr)
enzyme binding (Egfr) cytoplasm (Egfr) signal transducer activity (Egfr)
Anatomy Link Frequency
basal layer 2
Schwann cells 2
Egfr (Rattus norvegicus)
Pain Link Frequency Relevance Heat
cINOD 24 99.14 Very High Very High Very High
Inflammation 115 62.52 Quite High
cytokine 63 42.08 Quite Low
COX2 6 25.00 Low Low
Pain 3 5.36 Low Low
Inflammatory mediators 24 5.00 Very Low Very Low Very Low
Sciatic nerve 17 5.00 Very Low Very Low Very Low
chemokine 17 5.00 Very Low Very Low Very Low
Inflammatory response 11 5.00 Very Low Very Low Very Low
Spinal cord 10 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cholesteatoma 48 99.96 Very High Very High Very High
Leukemia 1 95.68 Very High Very High Very High
Injury 26 94.40 High High
Cancer 4 93.00 High High
Hyperplasia 4 90.72 High High
Apoptosis 9 86.60 High High
Reprotox - General 1 3 80.40 Quite High
Metaplasia 4 69.16 Quite High
Infection 14 63.92 Quite High
INFLAMMATION 151 62.52 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The levels of c-erbB receptor expression by Schwann cells, and the degree to which axons regenerated into the distal stumps both decreased with an increased period of denervation.
Negative_regulation (decreased) of Gene_expression (expression) of erbB in Schwann cells
1) Confidence 0.42 Published 2008 Journal BMC Neurosci Section Body Doc Link PMC2556676 Disease Relevance 0.26 Pain Relevance 0
Immunohistochemical and Western blot analysis were done to determine COX-2, epidermal growth factor receptor (EGFR), Akt, androgen receptor, and cyclin D1 expression.
Spec (determine) Negative_regulation (determine) of Gene_expression (expression) of epidermal growth factor receptor
2) Confidence 0.40 Published 2007 Journal Clin. Cancer Res. Section Body Doc Link 17908994 Disease Relevance 0.08 Pain Relevance 0
Immunohistochemical and Western blot analysis were done to determine COX-2, epidermal growth factor receptor (EGFR), Akt, androgen receptor, and cyclin D1 expression.
Spec (determine) Negative_regulation (determine) of Gene_expression (expression) of EGFR
3) Confidence 0.40 Published 2007 Journal Clin. Cancer Res. Section Body Doc Link 17908994 Disease Relevance 0.08 Pain Relevance 0
A strong inhibition of total and phosphorylated form of EGFR (Tyr(992) and Tyr(845)) and Akt (Ser(473)) was significant in rats given with these agents in combination.
Negative_regulation (inhibition) of Gene_expression (form) of EGFR
4) Confidence 0.40 Published 2007 Journal Clin. Cancer Res. Section Body Doc Link 17908994 Disease Relevance 0.05 Pain Relevance 0
Patients on either NSAID or COX-2 therapy had an increased p53 and decreased EGFR expression.
Negative_regulation (decreased) of Gene_expression (expression) of EGFR associated with cinod
5) Confidence 0.22 Published 2005 Journal Int J Immunopathol Pharmacol Section Abstract Doc Link 15698513 Disease Relevance 0.22 Pain Relevance 0.59
PPI therapy reversed not only the increased cell proliferation and p53 expression, but also the suppressed EGFR expression when administered as co-therapy.
Negative_regulation (reversed) of Gene_expression (expression) of EGFR
6) Confidence 0.22 Published 2005 Journal Int J Immunopathol Pharmacol Section Abstract Doc Link 15698513 Disease Relevance 0.22 Pain Relevance 0.59
PPI therapy reversed not only the increased cell proliferation and p53 expression, but also the suppressed EGFR expression when administered as co-therapy.
Negative_regulation (suppressed) of Gene_expression (expression) of EGFR
7) Confidence 0.22 Published 2005 Journal Int J Immunopathol Pharmacol Section Abstract Doc Link 15698513 Disease Relevance 0.21 Pain Relevance 0.57
In cholesteatoma, EGFR expression is not limited to the basal layer, as it is in normal squamous epithelia.
Neg (not) Negative_regulation (limited) of Gene_expression (expression) of EGFR in basal layer associated with cholesteatoma
8) Confidence 0.06 Published 2008 Journal Clinical and Experimental Otorhinolaryngology Section Body Doc Link PMC2671742 Disease Relevance 0.85 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox